SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001582629-17-000001
Filing Date
2017-03-06
Accepted
2017-03-06 16:19:14
Documents
1
Period of Report
2017-02-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1419
  Complete submission text file 0001582629-17-000001.txt   3115
Mailing Address 655 MONTGOMERY STREET SUITE 900 SAN FRANCISCO CA 94111
Business Address 655 MONTGOMERY STREET SUITE 900 SAN FRANCISCO CA 94111 (408) 737-2734
Amarantus Bioscience Holdings, Inc. (Issuer) CIK: 0001424812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 1601 BLAKE STREET SUITE 310 DENVER CO 80202
Business Address
Flanigan Conn (Reporting) CIK: 0001582629 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55016 | Film No.: 17668114